Medicinal Chemistry Consulting Services

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH NIDA

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N95022P00396

NAICS

541990 - All Other Professional, Scientific, and Technical Services

Classification Code

AN11

Additional Details
Set Aside

SBA

Place of Performance

-

SourceSAM
The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), has issued an award notice for Medicinal Chemistry Consulting Services under procurement identifier 75N95022P00396. This procurement falls under the North American Industry Classification System (NAICS) code 541990, which encompasses "All Other Professional, Scientific, and Technical Services," indicating a broad scope for specialized consulting activities that do not fit into more narrowly defined categories. The primary objective of this contract is to secure expert consulting services in medicinal chemistry, supporting NIDA’s mission to advance scientific research and development in the field of drug abuse and addiction. The intended outcome is to leverage specialized knowledge and technical expertise to inform and enhance ongoing and future research initiatives, potentially impacting the development of new therapeutic agents or methodologies. Key requirements for this engagement likely include a deep understanding of medicinal chemistry principles, experience with drug discovery and development processes, and the ability to provide strategic guidance on complex scientific challenges. While specific deliverables are not detailed in the notice, contractors can expect to be tasked with providing expert analysis, recommendations, and possibly contributing to the design or evaluation of research protocols and chemical compounds relevant to NIDA’s research portfolio. This opportunity is classified under Product Service Code AN11, further indicating its focus on professional consulting services within the scientific domain. The contract is set aside for Small Business Administration (SBA) eligible entities, reflecting NIH’s commitment to supporting small businesses and fostering innovation through diverse participation. The place of performance is within the United States, and the contracting activity is managed by the NIH NIDA office. Interested parties or awardees can direct inquiries to the primary contact, Marlene Milgram, who can be reached at [email protected] or by phone at 301-594-0864. The notice remains active as of its posting date, July 28, 2022, and is accessible via the official SAM.gov portal (Opportunity ID: bfbabddf6def44d89a8f1a6bb4a8de76). No additional documents or attachments are currently associated with the notice. Contractors considering this opportunity should ensure their capabilities align with the specialized nature of medicinal chemistry consulting and the broader scientific and technical requirements outlined by NIH NIDA. The SBA set-aside status and federal contracting environment further underscore the importance of compliance with relevant regulations and eligibility criteria throughout the contract lifecycle.